AICARExplore study findings
What AICAR did during DNA copying in esophageal cancer cells
1 numbered sourceSource years 2026
A peptide is a short chain of amino acids joined by peptide bonds. Some peptides relay signals between cells. AICAR, also called acadesine, is a ribonucleoside rather than an amino-acid chain. Cells can convert it into a nucleotide called ZMP, which can activate an energy-sensing enzyme called AMPK. In a 2026 cell study, researchers asked how that metabolic signal changed the progress of esophageal cells through the steps of cell division. [1]
The investigators compared two lines of esophageal squamous cell carcinoma with a line of esophageal epithelial cells. AICAR reduced proliferation in all three lines, but the cancer cells showed a distinctive accumulation in S phase, the part of the cell cycle when DNA is copied. The team traced the difference to changes in two protein complexes called mTORC1 and mTORC2 and their downstream signals. These complexes can help govern cell growth and how cells respond to available energy and nutrients. [1]
The experiment also examined a second drug, SN38, under controlled conditions after AICAR exposure. The design was based on a timing question. If more cancer cells were held at a stage where they copy DNA, would those cells become more sensitive to a compound that interferes with that process? The authors reported more programmed cell death under the tested sequence. [1]
These results describe cell lines and a specified experimental sequence. They support investigation of how cell-cycle timing and metabolism interact. A tumor in a person contains more kinds of cells, receives nutrients and drugs through a blood supply, and can behave differently from a laboratory culture. The study gives no human response rate or clinical safety outcome for either AICAR or the tested sequence. [1]
Sources
Original works cited in this article. Links open the external record in a new tab.
